focus -WSS

focus

author：explore 2025-08-19 06:17:30 - browse：1171

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Bacterial infection may be ‘key event’ in endometriosis, study says

entertainment

WSS

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Novo Nordisk testing Wegovy against alcohol

Doctor appointment wait times are getting worse

Can food be medicine? And other questions about a new push

Listen: PBM conflicts, RSV vaccines, & the future of flu season

RaDonda Vaught case: a double standard for nurses, physicians

entertainment

focus

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

Cherokee Nation medical school graduates its first class

Activists slam private health insurers over coverage restrictions

These geoengineering technologies could help combat the climate crisis, scientists say

Dobbs anniversary: the lost opportunity of abortion as health care

Why is France rioting? What to know about the fatal police shooting of Nahel M

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Inside the fall of star MIT scientist David Sabatini

State Dept. review finds Biden bears some blame for Afghanistan failures

Ripples from Flovent's discontinuation is killing children with asthma

leisure time

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Pfizer's Covid pill remains 89% effective in final analysis, company says

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Fertility clinic egg and embryo storage is a disaster

The White House hikes tariffs on plastic syringes made in China

Free medical tuition alone isn't enough to close gaps in primary care

knowledge

focus

entertainment

explore